-
Genetic Testing GapsTesting for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.
by Kate Yandell
-
From the Editor-in-Chief
The Tumor MicroenvironmentResearch is leading to treatments that target cancer's support system.
by William G. Nelson, MD, PhD
-
May 21: The Week in Cancer NewsThe U.S. Preventive Services Task Force lowers its recommended age to begin colorectal cancer screening to 45, and a major multiple myeloma study begins in Iceland.
by Bradley Jones
-
Expanding ImmunotherapyAt a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.
by Kevin McLaughlin
-
Forward Look
First CAR-T Cell Therapy Approved for Multiple MyelomaCellular immunotherapies can offer periods when people do not require treatment.
by Christina Bennett
-
Forward Look
Going FlatMost people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.
by Kris Conner
-
Should All Kids With Cancer Get Genetic Testing?Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.
by Marcus A. Banks
-
Forward Look
The Impact of HPV VaccinationOver a decade after human papillomavirus vaccines first became available in the U.S., their effect on cervical cancer incidence is becoming apparent.
by Carisa D. Brewster
-
Forward Look
What’s Next?Using fecal transplants to improve immunotherapy response
by Natalie Slivinski
-
Understanding How Radiation Causes CancerResearchers are investigating who is at greatest risk for radiation-induced cancers.
by Kate Yandell
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
